BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1588459)

  • 41. A Holistic Approach of Extractables and Leachables Assessment of Rubber Stoppered Glass Vial Systems for Biotechnology Products.
    Qi L; Liu J; Ronk M; Gallegos A; Fujimori K; Luo Y; Li K; Lee H; Nashed-Samuel Y
    J Pharm Sci; 2021 Nov; 110(11):3580-3593. PubMed ID: 34324943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone.
    Pikal MJ; Dellerman K; Roy ML
    Dev Biol Stand; 1992; 74():21-37; discussion 37-8. PubMed ID: 1592171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantifying the Vial-Capping Process: Reexamination Using Micro-Computed Tomography.
    Ovadia R; Lam P; Tegoulia V; Maa YF
    PDA J Pharm Sci Technol; 2020; 74(2):171-184. PubMed ID: 31420506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of laboratory and production freeze drying cycles.
    Kuu WY; Hardwick LM; Akers MJ
    Int J Pharm; 2005 Sep; 302(1-2):56-67. PubMed ID: 16099610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determining Maximum Allowable Rubber Stopper Displacement for Container Closure Integrity (CCI).
    Nonis L; Vogt M; Joerg S; Mahler HC; Riesen F; Roidl G; Sabini F; Mathaes R
    PDA J Pharm Sci Technol; 2020; 74(6):688-692. PubMed ID: 32540864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11).
    Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S
    Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of controlled ice nucleation on primary drying stage and protein recovery in vials cooled in a modified freeze-dryer.
    Passot S; Tréléa IC; Marin M; Galan M; Morris GJ; Fonseca F
    J Biomech Eng; 2009 Jul; 131(7):074511. PubMed ID: 19640147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lyophilization cycle development for interleukin-2.
    Vemuri S
    Dev Biol Stand; 1992; 74():341-51. PubMed ID: 1592183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality control issues in the analysis of lyophilized proteins.
    Baffi RA; Garnick RL
    Dev Biol Stand; 1992; 74():181-4. PubMed ID: 1592167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cleanliness assessment of supplier-cleaned stoppers.
    Townsend MW; Conti B; Hazrati A; DeLuca PP
    J Parenter Sci Technol; 1989; 43(2):98-102. PubMed ID: 2709242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug interactions with potential rubber closure extractables. Identification of thiol-disulfide exchange reaction products of captopril and thiurams.
    Corredor C; Tomasella FP; Young J
    J Chromatogr A; 2009 Jan; 1216(1):43-8. PubMed ID: 19041978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Particulate contamination from siliconized rubber closures for freeze drying.
    Gebhardt U; Grumbridge NA; Knoch A
    PDA J Pharm Sci Technol; 1996; 50(1):24-9. PubMed ID: 8846053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current perspectives on stability of protein drug products during formulation, fill and finish operations.
    Rathore N; Rajan RS
    Biotechnol Prog; 2008; 24(3):504-14. PubMed ID: 18484778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Scanning electron microscopy of freeze-dried preparations: relationship of morphology to freeze-drying parameters.
    Dawson PJ; Hockley DJ
    Dev Biol Stand; 1992; 74():185-92. PubMed ID: 1592168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of Patient Exposure to Leachables From Lyophilized Drug Formulations Following Reconstitution, Storage, and Administration via Polymeric Packaging/Delivery Systems.
    Zdravkovic SA
    J Pharm Sci; 2018 Nov; 107(11):2837-2846. PubMed ID: 30005987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time-dependence of pressure in lyophilization vials.
    Crist B
    PDA J Pharm Sci Technol; 1994; 48(4):189-96. PubMed ID: 7804818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Studies on the absorption of phenyl mercuric nitrate in the stoppers for injection vials].
    Kristensen AK; Mortensen JR
    Dan Tidsskr Farm; 1968; 42(5):132-6. PubMed ID: 5710078
    [No Abstract]   [Full Text] [Related]  

  • 58. Impact of extractables from rubber closures on protein stability under heat stress.
    Richter C; Lipperheide C; Lipke U; Lamprecht A
    Eur J Pharm Biopharm; 2018 Sep; 130():22-29. PubMed ID: 29894815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The incidence of coring with blunt versus sharp needles.
    Wani T; Wadhwa A; Tobias JD
    J Clin Anesth; 2014 Mar; 26(2):152-4. PubMed ID: 24582180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of moisture in rubber stoppers: effect of Karl Fischer oven temperatures.
    Wang Z; Frankel BA; Lambert WJ
    PDA J Pharm Sci Technol; 2001; 55(3):162-70. PubMed ID: 11417106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.